The content on this site is intended for healthcare professionals only
Dr Rajiv Yadav talks to ecancer at the 1st Indian Cancer Conference about a recent study examining the efficacy of treating localised prostate cancer with robotic surgery.
The study involved 150 patients over the past two years and looked at the patient’s quality of life after the procedure.
Pembrolizumab alone achieves bladder preservation and ctDNA predicts outcomes in muscle-invasive bladder cancer
AMVAC plus nivolumab in muscle-invasive bladder cancer preserves bladder and predicts metastatic control with ctDNA
Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns
Addition of radical prostatectomy to systemic treatment improves survival in oligometastatic prostate cancer
Laser oncosurgery - A new perspective in treating cancer
Choosing the right patients for transplant
ESMO 2024: Highlights and analysis
Understanding the use of PARPi combinations to treat patients with mCRPC
ESMO 2024: Optimising the personalisation of prostate cancer treatment
